跳至主要内容
临床试验/NCT00915629
NCT00915629终止不适用

Prevention of Recurrent Vulvovaginal Candidiasis With Lactibiane Candisis 5M®

PiLeJe2 个研究点 分布在 1 个国家目标入组 134 人开始时间: 2009年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
PiLeJe
入组人数
134
试验地点
2
主要终点
The primary objective of this study was to investigate if Lactibiane candisis 5M supplementation could lengthen the time to relapse after initial local cure

研究概览

简要总结

Vulvovaginal candidiasis (VVC) is a common infection among women that is associated with considerable morbidity and health-care cost. 75% of women will suffer of Candida infection for at least one time in their life. 20% of women who suffer from VVC will have ≥ 4 episodes of VVC during the one year prior to the survey. 80% of these VVC are caused by Candida albicans. Current treatments, based on imidazoles, face many failures or recurrences. The type of probiotic Lactobacillus may participate in the prevention of recurrent vulvo-vaginitis in reducing the proliferation of intestinal Candida albicans, its adherence to the vaginal walls, the potentiation of its propagation. The primary objective of this study was to investigate if our supplementary treatment could improve the initial cure rate after vaginal econazole therapy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • 18-65 years
  • suffering from 4 or more episodes of VVC during the 1 year prior to the survey
  • all participants must be symptomatic with a microbiological proof of infection with candida albicans

排除标准

  • Pregnancy, lactation being
  • HIV infection, chemotherapy or illness serious enough to induce an immune deficiency. A diabetic patient will not be systematically excluded;
  • Vulvo-vaginitis and / or cervicitis specific, defined in a bacteriological examination by the presence of herpes virus, gonorrhea or chlamydia;
  • Bacterial Vaginosis or Trichomonas;
  • Use of vaginal probiotics in the months before inclusion;
  • Cure of probiotics in the months preceding the inclusion;
  • Contraindication to Gynopévaryl LP

结局指标

主要结局

The primary objective of this study was to investigate if Lactibiane candisis 5M supplementation could lengthen the time to relapse after initial local cure

时间窗: 9 months

次要结局

  • The secondary objective of this study is to compare the number of recurrence in the lactibiane candisis 5M group versus placebo.(2, 3, 6 and 9 months)

研究者

发起方
PiLeJe
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验